Surgery Medical News about Neuroblastoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma
American Journal of Surgical Pathology , 10/28/09

Krishnan C et al. – MAP–2 is a sensitive and specific marker of neuroblastoma, both in the primary tumor and bone marrow biopsy settings. The authors think that MAP–2, in conjunction with synaptophysin, is a very powerful immunohistochemical marker in differentiating neuroblastoma from its morphologic mimics.

<< Previous
Risk factors of atrial fibrillation following off-pump coronary...

Next >>
Overlapping Features Between Dedifferentiated Liposarcoma and...

Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
Oncogene, 11/12/09 Relevance Score: 89%

Interferon-gamma–Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo
Clinical Cancer Research, 10/19/09 Relevance Score: 88%

Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Expert Opinion on Investigational Drugs, 10/12/09 Relevance Score: 88%

Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy
Pediatric Radiology, 10/05/09 Relevance Score: 88%

Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells
Molecular Cancer, 10/02/09 Relevance Score: 88%